Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (not Vivani Medical, Inc.) on January 3, 2017. The report discloses the grant of stock options to certain officers and employees under the company's 2011 Equity Incentive Plan, effective after trading hours on the report date.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. The only financial data disclosed relates to the equity compensation grant:
- Strike Price: $1.97 per share (closing price on the grant date).
- Total Options Granted to Listed Officers: 1,609,920 shares.
Material Changes
The material change reported is the issuance of new equity awards to key personnel. No changes to financial performance or operational status are detailed in this specific filing.
Guidance, Outlook, and Risks
The filing contains no management guidance, outlook, or discussion of risks and contingencies. It strictly reports the terms of the option grants, which vest over a four-year period (25% after one year, with the remainder vesting quarterly).
Important Facts for Investors to Verify
- Company Identity: Verify that the filing pertains to Second Sight Medical Products, Inc., as the metadata reference to "Vivani Medical, Inc." appears to be incorrect based on the document text.
- Option Terms: Confirm the vesting schedule and strike price ($1.97) for the 1,609,920 options granted to executives including the CEO, CFO, and Chairman.
- Dilution Impact: Assess the potential dilution effect of these grants on existing shareholders.